Cardiovascular Injury Due to SARS-CoV-2
Current Clinical Microbiology Reports · 2021-09 · 8 (3) · 167-177
DOI: 10.1007/s40588-021-00160-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Clinical Microbiology Reports, online erschienen am 05.03.2021. Verfasst von Christina L Bugert und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life and Environmental Sciences, University of Exeter, Exeter, South West UK. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association, Florida State University - Office of Research Development - Collaborative Collision: Covid-19 Pandemic.
Abstract (Originalsprache)
Purpose of Review: The world is currently facing the largest global health crisis since the early 1900s due to a novel coronavirus. While SARS-CoV-2 infection causes predictable symptoms in COVID-19 patients, including upper respiratory distress and fever, the heterogeneity of manifestations is surprising. This review focuses on direct and indirect causes of myocardial injury in COVID-19 patients and highlights current knowledge, treatment strategies, and outstanding questions in the field. Recent Findings: Data are emerging that highlight the extent of cardiovascular involvement in COVID-19 patients, including evidence that SARS-CoV-2 causes myocarditis and increases cardiac risk. The incidence of cardiac injury is much greater in patients with severe disease presentation and those in intensive care. Summary: During the past year, COVID-19 patient mortality rates have improved due to tailored pharmacological treatments and patient management strategies that address the unique presentation of symptoms, which will hopefully also reduce the incidence of cardiac injury.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life and Environmental Sciences, University of Exeter, Exeter, South West UK.
- Department of Nutrition, Food and Exercise Sciences, Florida State University, Tallahassee, FL USA.
- Bundeswehr Institute of Microbiology, Munich, Germany.
ORCID-Profile: Michelle S Parvatiyar
Förderung
- American Heart Association
- Florida State University - Office of Research Development - Collaborative Collision: Covid-19 Pandemic
Zitieren
APA
Bugert, C. L., Kwiat, V., Valera, I. C., Bugert, J. J., & Parvatiyar, M. S. (2021). Cardiovascular Injury Due to SARS-CoV-2. Current Clinical Microbiology Reports, 8(3), 167-177. https://doi.org/10.1007/s40588-021-00160-0
Vancouver
Bugert CL, Kwiat V, Valera IC, Bugert JJ, Parvatiyar MS. Cardiovascular Injury Due to SARS-CoV-2. Current Clinical Microbiology Reports. 2021;8(3):167-177. doi:10.1007/s40588-021-00160-0
BibTeX
@article{Bugert2021,
author = {Bugert, Christina L and Kwiat, Victoria and Valera, Isela C and Bugert, Joachim J and Parvatiyar, Michelle S},
title = {Cardiovascular Injury Due to SARS-CoV-2},
journal = {Current Clinical Microbiology Reports},
year = {2021},
volume = {8},
number = {3},
pages = {167--177},
doi = {10.1007/s40588-021-00160-0}
}
EUVIMED